Related references
Note: Only part of the references are listed.CircPTK2 (hsa_circ_0005273) as a novel therapeutic target for metastatic colorectal cancer
Hongbao Yang et al.
MOLECULAR CANCER (2020)
Prognostic impact of ATM mutations in patients with metastatic colorectal cancer
Giovanni Randon et al.
SCIENTIFIC REPORTS (2019)
Inhibition of ATM reverses EMT and decreases metastatic potential of cisplatin-resistant lung cancer cells through JAK/STAT3/PD-L1 pathway
Mingjing Shen et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells
Nicholas R. Jette et al.
BRITISH JOURNAL OF CANCER (2019)
The Implications of Genetic Testing on Radiation Therapy Decisions: A Guide for Radiation Oncologists
Carmen Bergom et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
ATM orchestrates the DNA-damage response to counter toxic non-homologous end-joining at broken replication forks
Gabriel Balmus et al.
NATURE COMMUNICATIONS (2019)
FOXM1 promotes proliferation in human hepatocellular carcinoma cells by transcriptional activation of CCNB1
Na Chai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 with improved proof-reading enhances homology-directed repair
Tomoko Kato-Inui et al.
NUCLEIC ACIDS RESEARCH (2018)
The Human Transcription Factors (vol 172, pg 650, 2018)
Samuel A. Lambert et al.
CELL (2018)
Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines
Tahlita C. M. Zuiverloon et al.
BLADDER CANCER (2018)
Harnessing accurate non-homologous end joining for efficient precise deletion in CRISPR/Cas9-mediated genome editing
Tao Guo et al.
GENOME BIOLOGY (2018)
Non-homologous DNA end joining and alternative pathways to double-strand break repair
Howard H. Y. Chang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
ATM-Deficient Colorectal Cancer Cells Are Sensitive to the PARP Inhibitor Olaparib
Chen Wang et al.
TRANSLATIONAL ONCOLOGY (2017)
Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer
A. Gordon Robertson et al.
CELL (2017)
Error-Prone Repair of DNA Double-Strand Breaks
Kasey Rodgers et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2016)
Discovery of Novel 3-Quinoline Carboxamides as Potent, Selective, and Orally Bioavailable Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase
Sebastien L. Degorce et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Systematic quantification of HDR and NHEJ reveals effects of locus, nuclease, and cell type on genome-editing
Yuichiro Miyaoka et al.
SCIENTIFIC REPORTS (2016)
LCR-eXXXplorer: a web platform to search, visualize and share data for low complexity regions in protein sequences
Ioannis Kirmitzoglou et al.
BIOINFORMATICS (2015)
An Inhibitor of PIDDosome Formation
Ruth Thompson et al.
MOLECULAR CELL (2015)
BubR1 kinase: protection against aneuploidy and premature aging
Maria Kapanidou et al.
TRENDS IN MOLECULAR MEDICINE (2015)
FOXM1 binds directly to non-consensus sequences in the human genome
Deborah A. Sanders et al.
GENOME BIOLOGY (2015)
Comprehensive molecular profiling of lung adenocarcinoma
Eric A. Collisson et al.
NATURE (2014)
Is Non-Homologous End-Joining Really an Inherently Error-Prone Process?
Mireille Betermier et al.
PLOS GENETICS (2014)
Distinct Properties of Cell-Type-Specific and Shared Transcription Factor Binding Sites
Jason Gertz et al.
MOLECULAR CELL (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Genome-wide mapping of FOXM1 binding reveals co-binding with estrogen receptor alpha in breast cancer cells
Deborah A. Sanders et al.
GENOME BIOLOGY (2013)
Identification of FoxM1/Bub1b Signaling Pathway as a Required Component for Growth and Survival of Rhabdomyosarcoma
Xiaolin Wan et al.
CANCER RESEARCH (2012)
Structure of the mitotic checkpoint complex
William C. H. Chao et al.
NATURE (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Chemoradiation therapy in the management of gastrointestinal malignancies
Autumn J. McRee et al.
FUTURE ONCOLOGY (2011)
BubR1 blocks substrate recruitment to the APC/C in a KEN-box-dependent manner
Pablo Lara-Gonzalez et al.
JOURNAL OF CELL SCIENCE (2011)
BUB1 and BUBR1: multifaceted kinases of the cell cycle
Victor M. Bolanos-Garcia et al.
TRENDS IN BIOCHEMICAL SCIENCES (2011)
The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo
Victoria J. Weston et al.
BLOOD (2010)
Expression Signature of E2F1 and Its Associated Genes Predict Superficial to Invasive Progression of Bladder Tumors
Ju-Seog Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Activation and regulation of ATM kinase activity in response to DNA double-strand breaks
J-H Lee et al.
ONCOGENE (2007)
Transcription of the human cell cycle regulated BUB1B gene requires hStaf/ZNF143
Evelyne Myslinski et al.
NUCLEIC ACIDS RESEARCH (2007)
Regional copy number-independent deregulation of transcription in cancer
Nicolas Stransky et al.
NATURE GENETICS (2006)
BubR1 is involved in regulation of DNA damage responses
Y. Fang et al.
ONCOGENE (2006)
Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays
M Sanchez-Carbayo et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
SQ/TQ cluster domains: concentrated ATM/ATR kinase phosphorylation site regions in DNA-damage-response proteins
A Traven et al.
BIOESSAYS (2005)
FoxM1 is required for execution of the mitotic programme and chromosome stability
J Laoukili et al.
NATURE CELL BIOLOGY (2005)
Gene expression in the urinary bladder:: A common carcinoma in situ gene expression signature exists disregarding histopathological classification
L Dyrskjot et al.
CANCER RESEARCH (2004)
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
CJ Bakkenist et al.
NATURE (2003)
Checkpoint inhibition of the APC/C in HeLa cells is mediated by a complex of BUBR1, BUB3, CDC20, and MAD2
V Sudakin et al.
JOURNAL OF CELL BIOLOGY (2001)
Share Paper
